Mahmoud Abbas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mahmoud Abbas has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Viktor Grünwald
Interdisciplinary Genitourinary Oncology, Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, West-German Cancer Center Essen, University Hospital Essen, Essen, Germany
20 shared publications - Abdullah Alajati
Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany
19 shared publications - Alexander Mustea
Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany
19 shared publications - Andreas Manseck
25Department of Urology, Klinikum Ingolstadt, Ingolstadt, Germany
19 shared publications - Arndt Hartmann
Institute of Pathology University Hospital Erlangen, Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) Erlangen Germany
19 shared publications - Bernd Wullich
Urologische und Kinderurologische Klinik, Universitätsklinikum Erlangen, Erlangen, Deutschland
19 shared publications
Latest Publications
- Open Access
- 6 July 2026
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 32 (3) , 1-9
Role of fine‑needle aspiration cytology and cell morphology in determining the histogenesis of salivary gland lesions
Fine‑needle aspiration (FNA) of suspicious salivary and neck swellings is a simple and cost‑effective diagnostic method for the evaluation of inflammatory and neoplastic conditions. The aim of the present study was to evaluate the diagnostic accuracy of FNA cytology (FNAC) in determining the histogenesis of salivary gland lesions based on cytomorphological features and associated histopathological outcomes to refine diagnostic criteria and contribute to improved diagnostic accuracy in salivary gland cytopathology. FNA was performed in 544 patients at the Institute of Pathology, Hannover Medical School (Hannover, Germany). The cytological smears were stained with May‑Grunwald Giemsa, Papanicolaou and periodic acid‑Schiff and compared with histological specimens from the same patients using immunohistochemical and molecular methods. The samples were anonymized and analyzed retrospectively. Of the total cases, 422 (77.57%) were benign lesions, 59 (10.85%) were malignant lesions and 26 (4.78%) were normal cases. Insufficient material was obtained in 37/544 cases (6.80%). No complications were observed. The concordance with histological findings for neoplastic lesions was >97.5%, with a false negative rate of 1.7%. The sensitivity of the diagnostic methods was 94% and the specificity was 98%. Of the 544 cases, 283 were female (52%) and 261 were male (48%). The diagnostic value of FNAC in representative material was relatively high in distinguishing between benign and malignant lesions. Sensitivity and specificity were variable (60.0 ‑97.5%). Correct diagnosis in the head and neck region requires interdisciplinary integration of findings and pathological‑clinical cooperation.
- 6 July 2026
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 32 (3) , 1-9
Open AccessRole of fine‑needle aspiration cytology and cell morphology in determining the histogenesis of salivary gland lesions
Fine‑needle aspiration (FNA) of suspicious salivary and neck swellings is a simple and cost‑effective diagnostic method for the evaluation of inflammatory and neoplastic conditions. The aim of the present study was to evaluate the diagnostic accuracy of FNA cytology (FNAC) in determining the histogenesis of salivary gland lesions based on cytomorphological features and associated histopathological outcomes to refine diagnostic criteria and contribute to improved diagnostic accuracy in salivary gland cytopathology. FNA was performed in 544 patients at the Institute of Pathology, Hannover Medical School (Hannover, Germany). The cytological smears were stained with May‑Grunwald Giemsa, Papanicolaou and periodic acid‑Schiff and compared with histological specimens from the same patients using immunohistochemical and molecular methods. The samples were anonymized and analyzed retrospectively. Of the total cases, 422 (77.57%) were benign lesions, 59 (10.85%) were malignant lesions and 26 (4.78%) were normal cases. Insufficient material was obtained in 37/544 cases (6.80%). No complications were observed. The concordance with histological findings for neoplastic lesions was >97.5%, with a false negative rate of 1.7%. The sensitivity of the diagnostic methods was 94% and the specificity was 98%. Of the 544 cases, 283 were female (52%) and 261 were male (48%). The diagnostic value of FNAC in representative material was relatively high in distinguishing between benign and malignant lesions. Sensitivity and specificity were variable (60.0 ‑97.5%). Correct diagnosis in the head and neck region requires interdisciplinary integration of findings and pathological‑clinical cooperation.
- Open Access
- 12 December 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (12) , 234
Urine Cytological Diagnostics: Possibilities and Limitations—A 25-Year Review and Overview at Hannover Medical School
Background: Urine cytology is a highly effective, straightforward, and cost-efficient diagnostic tool for identifying neoplastic and non-neoplastic changes in the bladder, ureter, and renal pelvis. The aim of this study is to demonstrate the high sensitivity and specificity of urine cytology in detecting a wide range of urothelial lesions, including metastatic involvement. Material and Methods: Urine cytology was performed on 9639 cases between 2000 and 2025. The samples, collected from patients, were processed at the Institute of Pathology. Cytological slides were prepared using cytocentrifugation and stained with May–Grünwald–Giemsa (MGG) and Papanicolaou stains. The cytological findings were classified according to WHO, 2004 compared with histological specimens. Additionally, selected cases underwent immunohistochemical and molecular analyses. All samples were anonymized and retrospectively analyzed following the guidelines and regulations of the local ethics committee. Results: Of the total cases, 7051 were classified as benign, 1269 as malignant, and 88 as normal findings. Insufficient material was obtained in 336 cases. No complications were reported during sample collection or processing. The concordance with histological findings for neoplastic lesions was over 96%, with a false-negative rate of 1.84%. The diagnostic methods demonstrated a sensitivity of 90.7% and a specificity of 96.64%. Among the 6956 cases analyzed, 3139 were women (45.13%) and 3817 were men (54.87%). Conclusions: The diagnostic value of urine cytology in representative material is relatively high in assessing both the presence or absence of malignancy and, when applicable, the tumor grade. This large 25-year single-center review demonstrates that urine cytology retains high sensitivity and specificity for the detection of urothelial malignancy, particularly high-grade disease. However, the atypical category remains a major diagnostic challenge and contributes substantially to false-positive results.
- 12 December 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (12) , 234
Open AccessUrine Cytological Diagnostics: Possibilities and Limitations—A 25-Year Review and Overview at Hannover Medical School
Background: Urine cytology is a highly effective, straightforward, and cost-efficient diagnostic tool for identifying neoplastic and non-neoplastic changes in the bladder, ureter, and renal pelvis. The aim of this study is to demonstrate the high sensitivity and specificity of urine cytology in detecting a wide range of urothelial lesions, including metastatic involvement. Material and Methods: Urine cytology was performed on 9639 cases between 2000 and 2025. The samples, collected from patients, were processed at the Institute of Pathology. Cytological slides were prepared using cytocentrifugation and stained with May–Grünwald–Giemsa (MGG) and Papanicolaou stains. The cytological findings were classified according to WHO, 2004 compared with histological specimens. Additionally, selected cases underwent immunohistochemical and molecular analyses. All samples were anonymized and retrospectively analyzed following the guidelines and regulations of the local ethics committee. Results: Of the total cases, 7051 were classified as benign, 1269 as malignant, and 88 as normal findings. Insufficient material was obtained in 336 cases. No complications were reported during sample collection or processing. The concordance with histological findings for neoplastic lesions was over 96%, with a false-negative rate of 1.84%. The diagnostic methods demonstrated a sensitivity of 90.7% and a specificity of 96.64%. Among the 6956 cases analyzed, 3139 were women (45.13%) and 3817 were men (54.87%). Conclusions: The diagnostic value of urine cytology in representative material is relatively high in assessing both the presence or absence of malignancy and, when applicable, the tumor grade. This large 25-year single-center review demonstrates that urine cytology retains high sensitivity and specificity for the detection of urothelial malignancy, particularly high-grade disease. However, the atypical category remains a major diagnostic challenge and contributes substantially to false-positive results.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
Supplementary Figure 1. Expression of membranous NECTIN-4 in UC histology subtypes in PRIM (A) and MET (B). (C) depicts differential NECTIN-4 expression during metastatic spread. Intergroup comparison was calculated by non-parametric Kruskal-Wallis test.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
Supplementary Figure 1. Expression of membranous NECTIN-4 in UC histology subtypes in PRIM (A) and MET (B). (C) depicts differential NECTIN-4 expression during metastatic spread. Intergroup comparison was calculated by non-parametric Kruskal-Wallis test.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data TS1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
Supplementary Table 1. Clinico-pathological characteristics of the UC progression PRIM-MET study cohort. BRA=brain metastasis; HEP=hepatic metastasis; LYM=non-locoregionary lymph node metastasis; OSS=bone metastasis; OTH= metastasis at other locations including soft tissue; PER=peritoneal metastasis; PUL=pulmonary metastasis.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data TS1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
Supplementary Table 1. Clinico-pathological characteristics of the UC progression PRIM-MET study cohort. BRA=brain metastasis; HEP=hepatic metastasis; LYM=non-locoregionary lymph node metastasis; OSS=bone metastasis; OTH= metastasis at other locations including soft tissue; PER=peritoneal metastasis; PUL=pulmonary metastasis.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data TS2 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
Supplementary Table 2. Baseline characteristics of the multicenter EV cohort.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data TS2 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
Supplementary Table 2. Baseline characteristics of the multicenter EV cohort.
- Open Access
- 29 October 2025
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 31 (1) , 1-6
Hepatic perivascular epithelioid cell tumor: A rare mesenchymal tumor with epithelioid features: A case report
Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms characterized by distinctive histological and immunohistochemical features. The tumor family originally included renal angiomyolipoma and pulmonary clear cell ‘sugar’ tumor. The present report describes a case of a hepatic PEComa in a 43‑year‑old man with no comorbidities and otherwise good health, who presented with abdominal discomfort and right upper quadrant tenderness. Laboratory findings were unremarkable. The patient underwent robotic‑assisted left hemihepatectomy, and the results indicated negative margins. Histologically, the tumor consisted of epithelioid, polyhedral cells with central to eccentric nuclei and abundant eosinophilic cytoplasm, arranged in nests and separated by a delicate capillary network. Central necrosis was present, closely resembling hepatocellular carcinoma. Immunohistochemistry demonstrated strong expression of Melan‑A and HMB‑45, focal positivity for smooth muscle actin, and negativity for other lineage markers. The Ki‑67 proliferation index was in situ hybridization excluded a TFE3 gene rearrangement at Xp11.23, ruling out TFE3‑associated PEComa. The current case illustrated the diagnostic challenges of hepatic PEComas, given their rarity and morphologic overlap with primary liver tumors. It emphasizes the necessity of integrating histopathology, immunohistochemistry and molecular testing for accurate diagnosis, thereby guiding appropriate clinical management and avoiding misclassification.
- 29 October 2025
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 31 (1) , 1-6
Open AccessHepatic perivascular epithelioid cell tumor: A rare mesenchymal tumor with epithelioid features: A case report
Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms characterized by distinctive histological and immunohistochemical features. The tumor family originally included renal angiomyolipoma and pulmonary clear cell ‘sugar’ tumor. The present report describes a case of a hepatic PEComa in a 43‑year‑old man with no comorbidities and otherwise good health, who presented with abdominal discomfort and right upper quadrant tenderness. Laboratory findings were unremarkable. The patient underwent robotic‑assisted left hemihepatectomy, and the results indicated negative margins. Histologically, the tumor consisted of epithelioid, polyhedral cells with central to eccentric nuclei and abundant eosinophilic cytoplasm, arranged in nests and separated by a delicate capillary network. Central necrosis was present, closely resembling hepatocellular carcinoma. Immunohistochemistry demonstrated strong expression of Melan‑A and HMB‑45, focal positivity for smooth muscle actin, and negativity for other lineage markers. The Ki‑67 proliferation index was in situ hybridization excluded a TFE3 gene rearrangement at Xp11.23, ruling out TFE3‑associated PEComa. The current case illustrated the diagnostic challenges of hepatic PEComas, given their rarity and morphologic overlap with primary liver tumors. It emphasizes the necessity of integrating histopathology, immunohistochemistry and molecular testing for accurate diagnosis, thereby guiding appropriate clinical management and avoiding misclassification.
- Open Access
- 12 January 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (1) , e70347
Evaluation of the Value of Fine Needle Aspiration Cytology and Cell Morphology in Determining the Histogenesis of Pancreatic Lesions With Review of Literature, Overview and Cytological Experience of 25 Years: Original Research
Background and Aims: Benign lesions, inflammation, cysts and pseudocysts, as well as neoplasms of the exocrine and endocrine parts of the pancreas can be easily identified using cytological methods. The sensitivity and specificity can be increased with the help of additional examination methods. The sensitivity of intraoperative rapid cytology reaches about 99%. In the literature, the sensitivity reaches an average of about 85% for biopsies. The method is easy to use, has very low complication rates (1%–2%) and is safe for the patient. Methods: 1290 cytological samples from pancreatic lesions were processed in the institute of pathology at Hannover Medical School (MHH), as cytological smears and stained with Giemsa and PAS stains as conventional methods. They were compared with the histological specimens that were processed at the same institute. Immunocytochemistry and molecularpathology have been processed only in selected cases. In general, it is routine in the university that the patients give their written consent to participate in clinical studies. The local ethics committee has stated that there is no need for approval due to the retrospective nature of the study. Results: In this work, we detected 20.077% malignant lesions, 63.333% benign findings and inflammation, 7.441% pseudocysts and cysts. About 9.147% samples were unrepresentative due to insufficient number of cells. Conclusion: This work will highlight the importance of fine aspiration cytology (FNAC) of suspicious pancreatic lesions, its possibilities and limitations in routine diagnostics with discussing the differential diagnoses, pointing to its great value and safety for patients. FNAC is the gold standard, its power is strongly associated with high specificity and sensitivity in the diagnosis of pancreatic lesions, and is very useful in the differential diagnosis between malignant and inflammatory lesions in pancreas.
- 12 January 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (1) , e70347
Open AccessEvaluation of the Value of Fine Needle Aspiration Cytology and Cell Morphology in Determining the Histogenesis of Pancreatic Lesions With Review of Literature, Overview and Cytological Experience of 25 Years: Original Research
Background and Aims: Benign lesions, inflammation, cysts and pseudocysts, as well as neoplasms of the exocrine and endocrine parts of the pancreas can be easily identified using cytological methods. The sensitivity and specificity can be increased with the help of additional examination methods. The sensitivity of intraoperative rapid cytology reaches about 99%. In the literature, the sensitivity reaches an average of about 85% for biopsies. The method is easy to use, has very low complication rates (1%–2%) and is safe for the patient. Methods: 1290 cytological samples from pancreatic lesions were processed in the institute of pathology at Hannover Medical School (MHH), as cytological smears and stained with Giemsa and PAS stains as conventional methods. They were compared with the histological specimens that were processed at the same institute. Immunocytochemistry and molecularpathology have been processed only in selected cases. In general, it is routine in the university that the patients give their written consent to participate in clinical studies. The local ethics committee has stated that there is no need for approval due to the retrospective nature of the study. Results: In this work, we detected 20.077% malignant lesions, 63.333% benign findings and inflammation, 7.441% pseudocysts and cysts. About 9.147% samples were unrepresentative due to insufficient number of cells. Conclusion: This work will highlight the importance of fine aspiration cytology (FNAC) of suspicious pancreatic lesions, its possibilities and limitations in routine diagnostics with discussing the differential diagnoses, pointing to its great value and safety for patients. FNAC is the gold standard, its power is strongly associated with high specificity and sensitivity in the diagnosis of pancreatic lesions, and is very useful in the differential diagnosis between malignant and inflammatory lesions in pancreas.
- Open Access
- 31 July 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0305135
Deep learning identifies histopathologic changes in bladder cancers associated with smoke exposure status
Smoke exposure is associated with bladder cancer (BC). However, little is known about whether the histologic changes of BC can predict the status of smoke exposure. Given this knowledge gap, the current study investigated the potential association between histology images and smoke exposure status. A total of 483 whole-slide histology images of 285 unique cases of BC were available from multiple centers for BC diagnosis. A deep learning model was developed to predict the smoke exposure status and externally validated on BC cases. The development set consisted of 66 cases from two centers. The external validation consisted of 94 cases from remaining centers for patients who either never smoked cigarettes or were active smokers at the time of diagnosis. The threshold for binary categorization was fixed to the median confidence score (65) of the development set. On external validation, AUC was used to assess the randomness of predicted smoke status; we utilized latent feature presentation to determine common histologic patterns for smoke exposure status and mixed effect logistic regression models determined the parameter independence from BC grade, gender, time to diagnosis, and age at diagnosis. We used 2,000-times bootstrap resampling to estimate the 95% Confidence Interval (CI) on the external validation set. The results showed an AUC of 0.67 (95% CI: 0.58–0.76), indicating non-randomness of model classification, with a specificity of 51.2% and sensitivity of 82.2%. Multivariate analyses revealed that our model provided an independent predictor for smoke exposure status derived from histology images, with an odds ratio of 1.710 (95% CI: 1.148–2.54). Common histologic patterns of BC were found in active or never smokers. In conclusion, deep learning reveals histopathologic features of BC that are predictive of smoke exposure and, therefore, may provide valuable information regarding smoke exposure status.
- 31 July 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0305135
Open AccessDeep learning identifies histopathologic changes in bladder cancers associated with smoke exposure status
Smoke exposure is associated with bladder cancer (BC). However, little is known about whether the histologic changes of BC can predict the status of smoke exposure. Given this knowledge gap, the current study investigated the potential association between histology images and smoke exposure status. A total of 483 whole-slide histology images of 285 unique cases of BC were available from multiple centers for BC diagnosis. A deep learning model was developed to predict the smoke exposure status and externally validated on BC cases. The development set consisted of 66 cases from two centers. The external validation consisted of 94 cases from remaining centers for patients who either never smoked cigarettes or were active smokers at the time of diagnosis. The threshold for binary categorization was fixed to the median confidence score (65) of the development set. On external validation, AUC was used to assess the randomness of predicted smoke status; we utilized latent feature presentation to determine common histologic patterns for smoke exposure status and mixed effect logistic regression models determined the parameter independence from BC grade, gender, time to diagnosis, and age at diagnosis. We used 2,000-times bootstrap resampling to estimate the 95% Confidence Interval (CI) on the external validation set. The results showed an AUC of 0.67 (95% CI: 0.58–0.76), indicating non-randomness of model classification, with a specificity of 51.2% and sensitivity of 82.2%. Multivariate analyses revealed that our model provided an independent predictor for smoke exposure status derived from histology images, with an odds ratio of 1.710 (95% CI: 1.148–2.54). Common histologic patterns of BC were found in active or never smokers. In conclusion, deep learning reveals histopathologic features of BC that are predictive of smoke exposure and, therefore, may provide valuable information regarding smoke exposure status.
- Open Access
- 4 March 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-30
Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology
Prostate cancer pathology plays a crucial role in clinical management but is time-consuming. Artificial intelligence (AI) shows promise in detecting prostate cancer and grading patterns. We tested an AI-based digital twin of a pathologist, vPatho, on 2603 histological images of prostate tissue stained with hematoxylin and eosin. We analyzed various factors influencing tumor grade discordance between the vPatho system and six human pathologists. Our results demonstrated that vPatho achieved comparable performance in prostate cancer detection and tumor volume estimation, as reported in the literature. The concordance levels between vPatho and human pathologists were examined. Notably, moderate to substantial agreement was observed in identifying complementary histological features such as ductal, cribriform, nerve, blood vessel, and lymphocyte infiltration. However, concordance in tumor grading decreased when applied to prostatectomy specimens (κ = 0.44) compared to biopsy cores (κ = 0.70). Adjusting the decision threshold for the secondary Gleason pattern from 5 to 10% improved the concordance level between pathologists and vPatho for tumor grading on prostatectomy specimens (κ from 0.44 to 0.64). Potential causes of grade discordance included the vertical extent of tumors toward the prostate boundary and the proportions of slides with prostate cancer. Gleason pattern 4 was particularly associated with this population. Notably, the grade according to vPatho was not specific to any of the six pathologists involved in routine clinical grading. In conclusion, our study highlights the potential utility of AI in developing a digital twin for a pathologist. This approach can help uncover limitations in AI adoption and the practical application of the current grading system for prostate cancer pathology.
- 4 March 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-30
Open AccessCritical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology
Prostate cancer pathology plays a crucial role in clinical management but is time-consuming. Artificial intelligence (AI) shows promise in detecting prostate cancer and grading patterns. We tested an AI-based digital twin of a pathologist, vPatho, on 2603 histological images of prostate tissue stained with hematoxylin and eosin. We analyzed various factors influencing tumor grade discordance between the vPatho system and six human pathologists. Our results demonstrated that vPatho achieved comparable performance in prostate cancer detection and tumor volume estimation, as reported in the literature. The concordance levels between vPatho and human pathologists were examined. Notably, moderate to substantial agreement was observed in identifying complementary histological features such as ductal, cribriform, nerve, blood vessel, and lymphocyte infiltration. However, concordance in tumor grading decreased when applied to prostatectomy specimens (κ = 0.44) compared to biopsy cores (κ = 0.70). Adjusting the decision threshold for the secondary Gleason pattern from 5 to 10% improved the concordance level between pathologists and vPatho for tumor grading on prostatectomy specimens (κ from 0.44 to 0.64). Potential causes of grade discordance included the vertical extent of tumors toward the prostate boundary and the proportions of slides with prostate cancer. Gleason pattern 4 was particularly associated with this population. Notably, the grade according to vPatho was not specific to any of the six pathologists involved in routine clinical grading. In conclusion, our study highlights the potential utility of AI in developing a digital twin for a pathologist. This approach can help uncover limitations in AI adoption and the practical application of the current grading system for prostate cancer pathology.
- Open Access
- 23 October 2023
- Published by Spandidos Publications in Oncology Letters
- Vol. 26 (6) , 1-7
Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer
In metastatic or locally advanced urothelial carcinoma (UC), therapeutic options have been limited to chemotherapy and immune checkpoint inhibitors. Novel targets and drugs such as antibody drug conjugates have been developed, and enfortumab vedotin targeting nectin‑4 and sacituzumab govitecan (SG) targeting trophoblast cell surface antigen 2 (TROP‑2), the protein product of the TACSTD2 gene, have been approved. The expression of TROP‑2 was investigated within UC and other types of carcinomas, and within the tissue of different healthy organs to understand treatment responses and toxicities. The expression of TROP‑2 in the tissues of 42 patients with UC, 13 patients with other types of cancer and in the normal tissues of 11 patients was retrospectively analyzed. Immunohistochemical staining of the TROP‑2 protein was performed on a BenchMark ULTRA IHC/ISH System (Roche Tissue Diagnostics; Roche Diagnostics, Ltd.) according to accredited staining protocols in a routine immunohistochemistry accredited and certified facility of the laboratory of immunohistochemistry at the Institute of Pathology (Gerhard‑Domagk Institute)‑ University Hospital Muenster (UKM)‑Muenster‑Germany]. Different expression levels of TROP‑2 were observed, and the highest expression rate of TROP‑2 was observed in UC, independent of the tumor stage. However, normal urothelial cells had similar expression levels. Except for ductal carcinoma in situ, the expression of TROP‑2 was reduced in other types of cancer and in the healthy tissues from other organs, including pancreas, gall bladder, colon and prostate. Given the treatment response based on the expression level of TROP‑2, SG would be effective in almost all cases of UC. However, it would also have an effect on the normal urothelium.
- 23 October 2023
- Published by Spandidos Publications in Oncology Letters
- Vol. 26 (6) , 1-7
Open AccessImmunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer
In metastatic or locally advanced urothelial carcinoma (UC), therapeutic options have been limited to chemotherapy and immune checkpoint inhibitors. Novel targets and drugs such as antibody drug conjugates have been developed, and enfortumab vedotin targeting nectin‑4 and sacituzumab govitecan (SG) targeting trophoblast cell surface antigen 2 (TROP‑2), the protein product of the TACSTD2 gene, have been approved. The expression of TROP‑2 was investigated within UC and other types of carcinomas, and within the tissue of different healthy organs to understand treatment responses and toxicities. The expression of TROP‑2 in the tissues of 42 patients with UC, 13 patients with other types of cancer and in the normal tissues of 11 patients was retrospectively analyzed. Immunohistochemical staining of the TROP‑2 protein was performed on a BenchMark ULTRA IHC/ISH System (Roche Tissue Diagnostics; Roche Diagnostics, Ltd.) according to accredited staining protocols in a routine immunohistochemistry accredited and certified facility of the laboratory of immunohistochemistry at the Institute of Pathology (Gerhard‑Domagk Institute)‑ University Hospital Muenster (UKM)‑Muenster‑Germany]. Different expression levels of TROP‑2 were observed, and the highest expression rate of TROP‑2 was observed in UC, independent of the tumor stage. However, normal urothelial cells had similar expression levels. Except for ductal carcinoma in situ, the expression of TROP‑2 was reduced in other types of cancer and in the healthy tissues from other organs, including pancreas, gall bladder, colon and prostate. Given the treatment response based on the expression level of TROP‑2, SG would be effective in almost all cases of UC. However, it would also have an effect on the normal urothelium.